Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic condition involving the inflammation of the colon and small intestine. IBD affects as many as 1.4 million people in the U.S. alone and costs the health care industry over $1.7 billion annually. Managing IBD normally requires invasive and often discomfort...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansberry, David R, Shah, Kush, Agarwal, Prateek, Agarwal, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332167/
https://www.ncbi.nlm.nih.gov/pubmed/28286723
http://dx.doi.org/10.7759/cureus.1004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332167/
https://www.ncbi.nlm.nih.gov/pubmed/28286723
http://dx.doi.org/10.7759/cureus.1004

Ejemplares similares